BGM GROUP LTD (BGM) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:BGM • KYG7307E1237

1.12 USD
+0.04 (+3.7%)
Last: Feb 10, 2026, 11:38 AM
Fundamental Rating

2

Overall BGM gets a fundamental rating of 2 out of 10. We evaluated BGM against 191 industry peers in the Pharmaceuticals industry. The financial health of BGM is average, but there are quite some concerns on its profitability. BGM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • BGM had negative earnings in the past year.
  • In the past year BGM has reported a negative cash flow from operations.
  • In multiple years BGM reported negative net income over the last 5 years.
  • BGM had a positive operating cash flow in each of the past 5 years.
BGM Yearly Net Income VS EBIT VS OCF VS FCFBGM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

1.2 Ratios

  • With a decent Return On Assets value of -1.31%, BGM is doing good in the industry, outperforming 75.92% of the companies in the same industry.
  • BGM has a Return On Equity of -1.49%. This is in the better half of the industry: BGM outperforms 78.01% of its industry peers.
Industry RankSector Rank
ROA -1.31%
ROE -1.49%
ROIC N/A
ROA(3y)-5.41%
ROA(5y)-0.31%
ROE(3y)-6.51%
ROE(5y)1.12%
ROIC(3y)N/A
ROIC(5y)N/A
BGM Yearly ROA, ROE, ROICBGM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

  • BGM's Gross Margin of 19.41% is in line compared to the rest of the industry. BGM outperforms 53.40% of its industry peers.
  • In the last couple of years the Gross Margin of BGM has declined.
  • The Profit Margin and Operating Margin are not available for BGM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.4%
GM growth 5Y-4.83%
BGM Yearly Profit, Operating, Gross MarginsBGM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

4

2. Health

2.1 Basic Checks

  • BGM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • BGM has less shares outstanding than it did 1 year ago.
  • BGM has less shares outstanding than it did 5 years ago.
  • There is no outstanding debt for BGM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BGM Yearly Shares OutstandingBGM Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BGM Yearly Total Debt VS Total AssetsBGM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • BGM has an Altman-Z score of 4.42. This indicates that BGM is financially healthy and has little risk of bankruptcy at the moment.
  • BGM has a Altman-Z score of 4.42. This is in the better half of the industry: BGM outperforms 71.20% of its industry peers.
  • BGM has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of BGM (0.01) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 4.42
ROIC/WACCN/A
WACC8.13%
BGM Yearly LT Debt VS Equity VS FCFBGM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M 50M

2.3 Liquidity

  • BGM has a Current Ratio of 1.82. This is a normal value and indicates that BGM is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of BGM (1.82) is worse than 64.92% of its industry peers.
  • A Quick Ratio of 1.45 indicates that BGM should not have too much problems paying its short term obligations.
  • BGM's Quick ratio of 1.45 is on the low side compared to the rest of the industry. BGM is outperformed by 62.83% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.45
BGM Yearly Current Assets VS Current LiabilitesBGM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

0

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 74.40% over the past year.
  • BGM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.12%.
  • Measured over the past years, BGM shows a very negative growth in Revenue. The Revenue has been decreasing by -11.45% on average per year.
EPS 1Y (TTM)74.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-146.9%
Revenue 1Y (TTM)-10.12%
Revenue growth 3Y-23.97%
Revenue growth 5Y-11.45%
Sales Q2Q%13.92%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BGM Yearly Revenue VS EstimatesBGM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

0

4. Valuation

4.1 Price/Earnings Ratio

  • BGM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BGM Price Earnings VS Forward Price EarningsBGM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BGM Per share dataBGM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • BGM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BGM GROUP LTD

NASDAQ:BGM (2/10/2026, 11:38:05 AM)

1.12

+0.04 (+3.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)07-24
Earnings (Next)N/A
Inst Owners0.2%
Inst Owner ChangeN/A
Ins Owners25.02%
Ins Owner ChangeN/A
Market Cap181.96M
Revenue(TTM)26.85M
Net Income(TTM)-2.72M
AnalystsN/A
Price TargetN/A
Short Float %0.14%
Short Ratio4.94
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.78
P/FCF N/A
P/OCF N/A
P/B 1
P/tB 4.3
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.17
BVpS1.12
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.31%
ROE -1.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.41%
FCFM N/A
ROA(3y)-5.41%
ROA(5y)-0.31%
ROE(3y)-6.51%
ROE(5y)1.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.4%
GM growth 5Y-4.83%
F-Score3
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 151.04%
Cap/Sales 6.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.45
Altman-Z 4.42
F-Score3
WACC8.13%
ROIC/WACCN/A
Cap/Depr(3y)184.23%
Cap/Depr(5y)176.99%
Cap/Sales(3y)4.89%
Cap/Sales(5y)4.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-146.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.12%
Revenue growth 3Y-23.97%
Revenue growth 5Y-11.45%
Sales Q2Q%13.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-211.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-163.33%
OCF growth 3Y15.85%
OCF growth 5YN/A

BGM GROUP LTD / BGM FAQ

Can you provide the ChartMill fundamental rating for BGM GROUP LTD?

ChartMill assigns a fundamental rating of 2 / 10 to BGM.


Can you provide the valuation status for BGM GROUP LTD?

ChartMill assigns a valuation rating of 0 / 10 to BGM GROUP LTD (BGM). This can be considered as Overvalued.


Can you provide the profitability details for BGM GROUP LTD?

BGM GROUP LTD (BGM) has a profitability rating of 2 / 10.


How financially healthy is BGM GROUP LTD?

The financial health rating of BGM GROUP LTD (BGM) is 4 / 10.